Page last updated: 2024-08-22

ferric chloride and von Willebrand Diseases

ferric chloride has been researched along with von Willebrand Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chuah, MK; De Meyer, SF; Deckmyn, H; Lenting, PJ; Pareyn, I; Petrus, I; VandenDriessche, T; Vandeputte, N; Vanhoorelbeke, K	1
Bryant, A; Golder, M; Haberichter, S; Hegadorn, C; Lillicrap, D; Pruss, CM	1

Other Studies

2 other study(ies) available for ferric chloride and von Willebrand Diseases

Article	Year
Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease. Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:9 Topics: alpha 1-Antitrypsin; Animals; Bleeding Time; Chlorides; Cytomegalovirus; Disease Models, Animal; Factor VIII; Feasibility Studies; Ferric Compounds; Gene Transfer Techniques; Genetic Therapy; Humans; Liver; Mice; Mice, Knockout; Platelet Adhesiveness; Platelet Aggregation; Promoter Regions, Genetic; Severity of Illness Index; Thrombosis; Time Factors; von Willebrand Diseases; von Willebrand Factor	2008
Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W. Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:5 Topics: ADAMTS13 Protein; Animals; Blood Coagulation; Blotting, Western; Chlorides; Disease Models, Animal; Ferric Compounds; Gene Transfer Techniques; Genotype; HEK293 Cells; Humans; Infusions, Intravenous; Injections, Intravenous; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Weight; Mutagenesis, Site-Directed; Mutation; Phenotype; Platelet Activation; Protein Multimerization; Recombinant Proteins; Thrombosis; Time Factors; Transfection; von Willebrand Diseases; von Willebrand Factor	2012

Article

Year

Restoration of plasma von Willebrand factor deficiency is sufficient to correct thrombus formation after gene therapy for severe von Willebrand disease.

Arteriosclerosis, thrombosis, and vascular biology, 2008, Volume: 28, Issue:9

Topics: alpha 1-Antitrypsin; Animals; Bleeding Time; Chlorides; Cytomegalovirus; Disease Models, Animal; Factor VIII; Feasibility Studies; Ferric Compounds; Gene Transfer Techniques; Genetic Therapy; Humans; Liver; Mice; Mice, Knockout; Platelet Adhesiveness; Platelet Aggregation; Promoter Regions, Genetic; Severity of Illness Index; Thrombosis; Time Factors; von Willebrand Diseases; von Willebrand Factor

2008

Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.

Journal of thrombosis and haemostasis : JTH, 2012, Volume: 10, Issue:5

Topics: ADAMTS13 Protein; Animals; Blood Coagulation; Blotting, Western; Chlorides; Disease Models, Animal; Ferric Compounds; Gene Transfer Techniques; Genotype; HEK293 Cells; Humans; Infusions, Intravenous; Injections, Intravenous; Metalloendopeptidases; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Weight; Mutagenesis, Site-Directed; Mutation; Phenotype; Platelet Activation; Protein Multimerization; Recombinant Proteins; Thrombosis; Time Factors; Transfection; von Willebrand Diseases; von Willebrand Factor

2012